A contact lens solution
By utilizing clean microcapsule technology and the synergistic effect of SB-HA microcapsules, sodium thiosulfate, and sodium citrate, the problem of residual main active ingredients in contact lens care solutions has been solved, resulting in improved safety and cleaning power while reducing costs.
Patent Information
- Application Number
- CN202611096662.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-07-23
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2046-07-23
AI Technical Summary
Existing multi-functional contact lens solutions often contain residual active ingredients that may pose potential health risks, and they are also relatively expensive.
Employing clean microcapsule technology, the active ingredients are stably maintained and released in response through SB-HA microcapsules. The synergistic complex system of sodium thiosulfate and sodium citrate removes the main active ingredients of the contact lens solution from the lens surface.
It effectively inhibits the residue of the main active ingredient, improves the safety and cleaning power of the contact lens solution, achieves deep cleaning of the lenses, and reduces costs.
Smart Images

Figure CN122587822B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of specialized cleaning agents, and particularly relates to a contact lens care solution. Background Technology
[0002] Contact lens solution is a colorless and transparent liquid composed of sodium chloride and preservatives, and typically has functions such as care, cleaning, disinfection, storage, rinsing, moisturizing, and protein removal.
[0003] Early contact lens solutions came in three types: disinfectant, cleaning solution, and comfort solution. To use them, after removing the lenses, you would first apply the cleaning solution to the lenses, gently rub them with your fingers, rinse, and then soak them in the disinfectant solution. The next day, after wearing the lenses, you would use the comfort solution periodically, depending on any discomfort in your eyes. This method was not very convenient, and if the labels or packaging of the three solutions were similar, it was easy to make a mistake.
[0004] Therefore, with the continuous upgrading of contact lenses and the increasing variety of lens types, a new type of multifunctional contact lens care solution emerged in the 1990s and quickly became popular. This care solution integrates lens cleaning, disinfection, and comfort functions. Although the procedures for lens use and maintenance are the same as before, they can all be completed with one liquid, which is very convenient.
[0005] Currently, multifunctional contact lens solutions mainly use polyquaternary ammonium salts such as biguanide, and / or poloxamer (i.e., α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer), and / or disodium edetate (i.e., EDTA) as the core ingredients, which have cleaning, rinsing, disinfection and storage functions, and are suitable for most soft and silicone hydrogel lenses.
[0006] However, the main preservatives in these contact lens solutions often kill bacteria by disrupting microbial cell membranes. But prolonged contact with the ocular surface can be toxic to the corneal epithelial barrier. Many reports indicate that this toxicity clinically manifests as solution-induced corneal staining, with diffuse punctate epithelial staining appearing several hours after lens wear. Symptoms include dryness and a foreign body sensation. However, because this is self-limiting and gradually heals during the day, it is easily missed. Therefore, addressing the potential residual hazards of these main preservatives has become a major focus of current contact lens solution research and development.
[0007] Currently, most research focuses on preservatives, aiming to develop more novel, residue-free or low-residue, or non-toxic or less toxic main active ingredients. For example, povidone-iodine (PVP-I) possesses strong oxidizing properties, killing various pathogens by releasing free iodine, including the most difficult-to-kill Acanthamoeba cysts. Its cytotoxicity to corneal epithelial cells is lower than that of PHMB and three other bactericides, making it a novel, low-toxicity main active ingredient. It has already been commercially available in products such as Cleadew, but its cost is high, and it requires devices or tablets, making the overall system cost significantly higher than ordinary multi-purpose contact lens solutions. Another example is Alexidine, which is usually used in combination with biguanide to synergistically enhance its bactericidal and fungal killing effects. However, its mechanism of action is similar to PHMB, still carrying a low probability of causing corneal staining, and its cost is generally relatively higher than traditional contact lens solutions.
[0008] Therefore, there is an urgent need for a newer, more effective, safer, and lower-cost process to improve the safety and effectiveness of care solutions. Summary of the Invention
[0009] To address the common problems of existing multifunctional contact lens solutions, such as the easy residue of main active ingredients and potential harm to the human body, this invention provides a contact lens solution.
[0010] The main objective of this invention is: I. Adopting a completely new technical approach, using low-cost microencapsulation technology that can stably maintain and achieve responsive release to suppress the residue and accumulation of the main active ingredient; Second, ensure the cleaning solution has good cleaning power and a good effect on the skin.
[0011] To achieve the above objectives, the present invention adopts the following technical solution.
[0012] A contact lens care solution, The contact lens solution uses water as a solvent and comprises the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.3–1.9 ppm, clean microcapsules 0.008–0.015 g / 100mL, α-hydro-ω-hydroxypolyoxyethylene-polyoxypropylene-polyoxyethylene block copolymer 0.08–0.12 g / 100mL, hydroxypropyl methylcellulose 0.12–0.18 g / 100mL, disodium ethylenediaminetetraacetate 0.08–0.12 g / 100mL, sodium citrate 0.4–0.6 g / 100mL.
[0013] As a preferred option The contact lens solution also contains: Sodium chloride 0.28–0.42 g / 100mL, boric acid 0.44–0.66 g / 100mL, disodium hydrogen phosphate 0.80–1.20 g / 100mL.
[0014] As a preferred option The clean microcapsules are SB-HA microcapsules.
[0015] As a preferred option The SB-HA microcapsules are prepared by the following process: 1) Dissolve N,N-dimethylethylenediamine in an alcohol-water solution, then add sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir to react, then replace the precipitate with solvent and purify and dry to obtain SB intermediate; 2) Prepare a sodium hyaluronate solution, then add SB intermediate and mix well, then add 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide, stir the reaction and then purify and separate to obtain a white solid; 3) Dissolve the white solid in water and stir until homogeneous. Then add soluble calcium salt and organic sodium salt, titrate and sonicate to form a suspension. At the same time, prepare a mixed solution of sodium thiosulfate and organic sodium salt. Add the mixed solution to the suspension and continue sonication. After sonication, let it stand at room temperature to mature and separate to obtain SB-HA microcapsules.
[0016] As a preferred option Step 1) The alcohol-water solution is prepared by mixing anhydrous ethanol and water in a volume ratio of (3.5-4.5):1, and the amount used is 8-12 mL / g N,N-dimethylethylenediamine; In step 1), the amount of sodium 3-chloro-2-hydroxypropanesulfonate used is 2.0 to 2.5 g / g N,N-dimethylethylenediamine.
[0017] As a preferred option The reflux stirring reaction described in step 1) is carried out at 76–79 °C and maintained for 11–13 h. Step 1) The solvent displacement precipitation is achieved by removing ethanol under reduced pressure by rotary evaporation, adding acetone at a ratio of 15-25 mL / g N,N-dimethylethylenediamine, stirring in an ice-water bath for 25-35 min to form a precipitate, then filtering and washing with acetone at least 3 times before vacuum drying to obtain the SB intermediate.
[0018] As a preferred option Step 2) The sodium hyaluronate solution is prepared by dissolving sodium hyaluronate in MES buffer to a concentration of 8-12 g / L. The concentration of the MES buffer used is 0.08-0.12 mol / L, and the pH value is 5.2-5.8. Step 2) The amount of the SB intermediate used is 0.8–1.2 g / L sodium hyaluronate solution; Step 2) The amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride used is 1.5-2.5 g / L sodium hyaluronate solution; Step 2) The amount of N-strong succinimide used is 1.5 to 2.0 g / L sodium hyaluronate solution.
[0019] As a preferred option Step 2) The stirring reaction is carried out at 23-26 °C and 250-350 rpm for 22-26 h. Step 2) The purification and separation process involves at least three operation cycles. Each operation cycle includes, in sequence, filtration with an ultrafiltration tube with a molecular weight cutoff of 8-12 kDa, centrifugation to concentrate to 18-22 vol% of the original solution volume, and replenishment of deionized water to the original volume. After completion, an operation cycle of filtration-concentration-dilution is formed. In the last operation cycle, no deionized water is added and the solution is freeze-dried to obtain a white solid.
[0020] As a preferred option Step 3) The soluble calcium salt is calcium chloride; Step 3) The organic sodium salt is sodium citrate.
[0021] As a preferred option Step 3) The white solid is dissolved in water at a ratio of 1 g to (80-120) mL and stirred for 90-150 min. Then, the soluble calcium salt and organic sodium salt are dissolved in water to prepare 0.04-0.06 mol / L soluble calcium salt solution and 0.04-0.06 mol / L organic sodium salt solution, respectively. The soluble calcium salt solution is added at a ratio of 35-45 mL / g white solid and the organic sodium salt solution is added at a ratio of 15-25 mL / g white solid. Then, ultrasonic assembly is performed.
[0022] As a preferred option In step 3), the ultrasonic assembly process controls the ultrasonic probe power to be 180-220 W, forming a pulse work cycle with a work-interval ratio of 1:(0.8-1.2). The duration of a single pulse work cycle is 5-7 s, and the total ultrasonic assembly time is controlled to be 4-6 min.
[0023] As a preferred option The ultrasonic assembly process controls the ultrasonic probe power to be 180-220 W, forming a pulse work cycle with a work-interval ratio of 1:(0.8-1.2), the duration of a single pulse work cycle is 5-7 s, and the total ultrasonic assembly time is controlled to be 4-6 min.
[0024] As a preferred option Step 3) The concentration of sodium thiosulfate in the mixed solution is 35-45 g / L, the concentration of organic sodium salt is 35-45 g / L, and the amount of mixed solution used is 40-60 mL / g white solid.
[0025] As a preferred option Step 3) The mixed solution is added to the suspension at a rate of 8-12 vol% / min. During the addition process, the suspension is subjected to ultrasonic treatment at 80-120 W. After the addition is completed, ultrasonic treatment at 80-120 W is continued for 8-12 min.
[0026] As a preferred option Step 3) The room temperature static curing is carried out at 18-22 ℃ for 90-150 min. If gel blocks appear during the curing process, ultrasonic treatment with a 180-220 W probe is performed for 3-5 min before subsequent centrifugation. In large-scale industrial production, this probe-type ultrasonic treatment can be a necessary operation to ensure product quality stability. In small-scale experimental or pilot production stages, ultrasonic treatment can be performed depending on whether macroscopic gels appear. Step 3) The separation is carried out by centrifugation at 5500-6500 rpm for 8-12 min. After separation, the solid product is washed with deionized water at least twice and then dried to obtain SB-HA microcapsules.
[0027] The technical solution of this invention is based on our company's most mature and widely sold basic formula, which is improved by adding a brand-new cleaning microcapsule.
[0028] It should be noted that the microcapsules of this invention do not refer to traditional core-shell structured materials, but rather to microparticles that form a stable composite through self-assembly and fixed loading of active ingredients, and can achieve triggered response release during subsequent use.
[0029] Based on this, the present invention first achieves the construction of SB intermediates for microcapsules. The two main raw material components of SB intermediates are N,N-dimethylethylenediamine (DMEN) and sodium 3-chloro-2-hydroxypropanesulfonate (CHPS-Na). The tertiary amine nitrogen atom of DMEN can perform SN2 nucleophilic substitution on the chloroalkyl group in CHPS-Na. The substituted tertiary amine is transformed into a quaternary ammonium cation, which forms an intramolecular zwitterion pair with the adjacent sulfonic acid. The primary amine at the other end of the molecule does not participate in the quaternization reaction, thus retaining the active site for carboxyl coupling with sodium hyaluronate. Furthermore, the hydroxyl group in CHPS-Na is retained as a side group, which enhances the water solubility and hydrogen bonding ability of the microcapsules.
[0030] Subsequently, the SB intermediate was further modified with sodium hyaluronate (HA) to synthesize a white solid product. This process required ensuring that the pH of the MES buffer system was between 5.2 and 5.8. Within this pH range, the combined action of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and N-hydroxysuccinimide (NHS) enabled the carboxyl group on HA to be converted into the NHS active ester. At the same time, the primary amine of the SB intermediate formed a stable amide bond with this active ester, resulting in substitution.
[0031] The white solid product after substitution is grafted with SB groups. Its zwitterionic structure can generate strong electrostatic orientation of water molecules, thereby forming a hydration repulsion layer. It also deprives interfacial water molecules and destroys weak forces such as hydrogen bonds and hydrophobic interactions. At the same time, the carboxyl groups retained in the HA main chain and the sodium citrate released from the microparticle core can competitively chelate metal ions, weakening the stability of organometallic complexes. This makes it very effective in replacing and removing the three common and main active ingredients of lens care solutions that remain on the lens surface: polyhexamethylene biguanide hydrochloride (PHMB), hydroxypropyl methylcellulose (HPMC), and disodium ethylenediaminetetraacetate (EDTA-2Na).
[0032] Subsequently, this invention employs citrate ions and calcium ions to induce assembly of the resulting white solid. Calcium ions can form toothed coordination with carboxyl groups, pulling the SB-HA molecular chain inward. Then, citrate ions can chelate multiple calcium ions to form Ca... 2+ -Cit 3- -Ca 2+ The network induces the formation of intermolecular alignment and assembly. However, since SB-HA molecules themselves form entanglements in the preceding steps, this invention requires ultrasonic treatment for ultrasonic assembly. The collapse of cavitation bubbles formed by ultrasonic treatment generates high temperature and pressure to break the entanglements between SB-HA molecular chains, promoting chain segment extension and de-entanglement. The micro-jet shearing generated by ultrasonic treatment can apply directional shearing force to the extended SB-HA molecular chains, inducing them to align perpendicular to the shearing direction, thereby constructing the precursor. Based on this, this invention further introduces the immobilization of the effective components.
[0033] The main effective cleaning component in the cleaning microcapsules introduced in this invention is a synergistic composite system of sodium thiosulfate and sodium citrate. Sodium thiosulfate acts as a mild reducing agent, utilizing hydrogen bonding and the Ca²⁺ ions in the SB-HA polyelectrolyte network. 2+ / Cit 3- The physical confinement of the ion bridge is effectively immobilized, and sodium citrate interacts with Ca through its multidentate carboxylate group. 2+ A secondary coordination network is formed, anchoring thiosulfate ions in the confined aqueous phase region between the SB-HA sheets.
[0034] This immobilization mechanism significantly reduces the apparent diffusion coefficient of sodium thiosulfate during long-term storage of the care solution compared to common carrier-mixed immobilization, effectively inhibiting its premature redox reaction with polyhexamethylene biguanide hydrochloride and ensuring the shelf-life stability of the care solution's preservative system.
[0035] When in use, the cleansing microcapsules have a very unique response release mechanism, which is mainly manifested in the following three aspects: One of its core mechanisms is the release triggered by meibomian gland lipids deposited on the lens surface. During long-term use, the lens will adhere to and deposit meibomian gland paper components such as wax esters and cholesterol esters on its surface. These components will compete with the hydrophobic microdomains of the clean microcapsules of this method for hydrophobic interaction, thereby balancing the self-assembly of the microcapsules and realizing the release of the effective ingredients. Secondly, and equally importantly, lenses are usually coated with tears when cleaning is required. These tears contain approximately 150 mmol / L of sodium ions, creating a relatively high concentration of metal ions. These ions will exchange with the calcium ions in the cleaning microcapsules, which have been activated by lipids and other components, thus reducing the calcium content of the lenses. 2+ -Cit 3- -Ca 2+ When the network loses its metal ion nodes, the microcapsule particles will also disintegrate. Thirdly, it is triggered by usage conditions. Depending on the user's contact lens care habits, some users rub and clean their contact lenses when using the solution. This rubbing action can also create shear force to a certain extent, disrupting the network balance of the cleaning microcapsules and releasing the active ingredients.
[0036] As can be seen from the above description, the cleaning microcapsules in the contact lens solution of this invention mainly play a responsive active cleaning role. They can effectively remove the main specular impurities deposited on the surface of contact lenses under normal use, such as PHMB, HPMC, and EDTA-2Na. PHMB is a cationic polymer, and the HA backbone of SB-HA carries a large number of negatively charged carboxyl groups. Although the negatively charged carboxyl groups on the microcapsule surface may undergo reversible electrostatic adsorption with PHMB during storage, this adsorption only occurs at the outer hydration interface of the microcapsule and does not significantly affect the stability of the core active components. Furthermore, this adsorption is a dynamic equilibrium process. When the microcapsules contact the lens surface, the lipid-triggered mechanism preferentially overrides PHMB adsorption, ensuring the directional release of the active components to the lens interface. Subsequently, when SB-HA particles contact the lens surface and respond with release, the HA backbone undergoes polyelectrolyte complexation with PHMB. The reaction forms a soluble or dispersible HA-PHMB complex, competitively extracting PHMB from the lens surface. Simultaneously, sodium thiosulfate released from the microparticle core disrupts the polycationic charge regularity of PHMB through nucleophilic attack or the formation of soluble complexes, reducing its electrostatic affinity for corneal epithelium and proteins. Sodium thiosulfate can also form soluble adducts with PHMB, promoting its desorption from the lens surface. The zwitterionic structure of the SB side chain plays a role in this process by forming a rigid hydration layer, generating hydration repulsion pressure, and preventing the extracted PHMB from being re-adsorbed back onto the lens surface.
[0037] HPMC, however, is different. Its residue does not rely on electrostatic adsorption, but on the hydrogen bond network formed with the hydroxyl / carboxyl groups on the lens surface and the hydrophobic interaction of the hydrophobic water area. The zwitterionic structure of the SB side chain has a very strong hydration orientation ability, forming a high-density hydration layer on the lens surface. This competitively deprives HPMC of the interfacial water molecules required for its bonding with the lens surface, thus disrupting the stability of the hydrogen bond network. At the same time, the sheets released after the SB-HA microcapsules disintegrate can physically wedge into the interface between the HPMC adhesive film and the lens surface. The rigid hydration layer of the sheets generates a leverage peeling effect, which pries up the entire HPMC film.
[0038] EDTA-2Na cannot be directly adsorbed onto the negatively charged lens surface through electrostatic interactions, especially on silicone hydrogel carboxyl contact lenses. Its residue retention mechanism involves chelating Ca on the lens surface. 2+ / Mg 2+ They form metal complexes, anchored as metal ion bridges. Sodium citrate released from the SB-HA particle core competes with EDTA to chelate these metal ions. 3- With Ca 2+ Although its coordination constant is slightly lower than that of EDTA, under conditions of localized high-concentration pulsed release, it can preferentially destroy EDTA-Ca. 2+The equilibrium of the complex causes EDTA to lose its anchoring site. Simultaneously, the carboxyl groups of the HA backbone can co-chelate Ca with EDTA. 2+ It forms a soluble ternary complex, which is carried away by the residual liquid after contact lens care technology without leaving any residue.
[0039] Furthermore, this invention has discovered a new problem for long-term wear of lenses. In fact, PHMB in conventional contact lens solutions is not simply a residue, but rather acts as a chemical cross-linking agent. It is positively charged at physiological pH with positively charged lysozyme and lactoferrin in tears, and electrostatically adsorbs onto negatively charged sites on the lens surface. At this time, PHMB, as a polycation, competes with the negatively charged sites on the lens surface for anchoring. On the other hand, its flexible long chains anchor a multi-layer protein network to the lens surface through hydrophobic interactions and ion pairing with negatively charged groups at the ends of protein sugar chains, such as sialic acid residues. After long-term accumulation, it forms a chemically hardened layer that is denser than natural protein deposits and more difficult to be removed by surfactants.
[0040] However, the improved residue-free contact lens solution of this invention can effectively break down the hardened layer to a certain extent, achieving a deeper and more effective cleaning of contact lenses, especially for long-term quarterly / semi-annual disposable lenses. This is because the sodium thiosulfate in the cleaning microcapsules of this invention can reduce the disulfide bonds in the protein layer while reducing the biguanide structure of PHMB, reducing its cationic bridging ability as a cross-linking agent, thus relaxing the covalent and / or ionic cross-linking network inside the hardened layer. Meanwhile, sodium citrate strongly chelates common deposited ions such as calcium and magnesium ions on the protein layer and lens surface, destroying the metal ion bridges between proteins and between proteins and lenses, causing the hardened layer to lose its ionic bonding stability.
[0041] Then, the negatively charged carboxyl groups of the HA backbone form a polyelectrolyte complex with PHMB, competitively extracting PHMB from the protein layer. Once PHMB is extracted, lysozyme / lactoferrin loses its cross-linking anchor, and the protein network disintegrates into dispersed protein monomers or oligomers, ultimately revealing the zwitterionic structure (N) of the SB side chain. + -SO3 - (Yes) A super-rigid hydration layer is formed on the lens surface, generating hydration repulsion pressure that physically pushes the softened and decrosslinked protein fragments away from the lens surface. At the same time, the SB-HA 2D sheet wedged into the interface between the hardened layer and the lens substrate, achieving deep cleaning and peeling.
[0042] Meanwhile, the cleaning microcapsules of this invention are not in competition with the α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer (i.e., poloxamer) in the basic formula, but rather form a synergistic cleaning system. Poloxamer preferentially forms a micellar dispersion phase in the care solution and is adsorbed onto the lens surface. Its emulsification effect on lipids exposes more lipid-water interfaces. The SB-HA composite particles, with their size and mechanical collision kinetic energy, penetrate the surface layer of poloxamer and reach the lens deposit interface, achieving deep cleaning.
[0043] It should also be further noted that the basic formula of the care solution of this invention contains multiple sodium salts such as sodium chloride, sodium citrate, disodium hydrogen phosphate, and EDTA-2Na. This concentration is similar to that of tear fluid. + The concentrations are comparable or even higher, but the stability of the microcapsules during storage does not solely depend on Na. + The concentration does not depend on the overall SB-HA microcapsule polyelectrolyte network for Na+. + The kinetic barriers and thermodynamic resistance of penetration. During the normal shelf life of the care solution of this invention, Ca... 2+ With Cit 3- The multiple coordination network formed by HA carboxyl groups has significant coordination stabilization energy, and the Na in the nursing solution... + It is impossible to directly thermodynamically replace the coordination state of Ca. 2 + Meanwhile, Na + The effective diffusion coefficient is limited by the polyelectrolyte backbone, and the permeation flux is extremely low under network defect-free conditions. Experiments show that single Na... + Extremely high concentrations are required for the network to be gradually destroyed by pure osmotic pressure within its shelf life (currently estimated to be 12-24 months or more).
[0044] In contact lens cleaning scenarios, meibomian gland lipids deposited on the lens surface insert into the hydrophobic microdomains of the microcapsules, creating nanoscale cracks. These cracks allow Na... + Network accessibility experiences a significant leap, even with moderate Na+ concentrations. + It can then rapidly infiltrate through the cracks, weakening residual coordination stability through charge shielding, leading to network cascade collapse. Therefore, Na + In this invention, it is not a standalone trigger, but rather an amplifying agent that forms synergistically with lipids. Lipids can lower the trigger threshold by several times. + It accelerates collapse after the cracks open.
[0045] Similarly, mechanical shearing, by providing mechanical energy and transient cracks, can also be combined with Na. + Synergistically lowering the effective threshold. Under conditions of static storage, absence of lipid contamination, and no continuous mechanical disturbance, the total Na content of the nursing solution of this invention... +The concentration is much lower than that of Na alone. + The destruction threshold ensures shelf-life stability, while during use, lipid intercalation with tear Na+ + Collaboration enables the system to quickly enter the supercritical release zone, achieving responsive cleaning.
[0046] Similarly, the basic formula of the nursing solution of this invention also contains various oxygen-containing anion components such as disodium ethylenediaminetetraacetate and disodium hydrogen phosphate. EDTA-2Na, as a strong Ca2+, is used. 2+ Chelating agents, theoretically, possess the ability to disrupt microcapsule Ca2+. 2+ -Cit 3- The ability of coordination networks, however, is limited; the polyelectrolyte networks in the microcapsules are actually dense and negatively charged on the surface, which hinders the development of EDTA. 2- / 3- Electrostatic repulsion significantly reduces the effective diffusion flux. At appropriate concentrations, the etch rate of EDTA is much lower than the dynamic repair rate of the network, causing no macroscopic damage within its 24-month shelf life. Only when the concentration is increased to the supercritical region, and the diffusion flux exceeds the dynamic equilibrium threshold, does rapid network etching occur. Similarly, although external sodium citrate and disodium hydrogen phosphate contain substances that can react with Ca... 2+ Interacting anions, but Ca inside the microcapsule 2+ Fixed by multiple coordination groups, the free concentration is extremely low, insufficient to form competitive precipitation or coordination position exchange. Poloxamer, however, forms a reversible adsorption layer on the microcapsule surface through its hydrophobic-hydrophilic block structure. This not only does not corrode the microcapsules but also hinders the approach of other ions, playing a synergistic stabilizing role as an interfacial shield. It should be noted, however, that poloxamer mainly exists in the bulk of the contact lens solution as free micelles. Its adsorption on the microcapsule surface is dynamic, reversible, and involves low coverage, insufficient to form a complete physical shield. When high concentrations of lipids appear on the lens surface, the lipids can effectively displace the poloxamer adsorbed on the microcapsule surface through competitive hydrophobic interactions, restoring the exposure of the trigger sites on the microcapsule.
[0047] The beneficial effects of this invention are as follows: 1) This invention introduces cleaning microcapsules, whose immobilized active ingredients can effectively achieve proactive and responsive deep cleaning and removal of potentially harmful residues such as PHMB, HPMC and EDTA-2Na; 2) Although the active ingredients in the cleaning microcapsules are mutually exclusive with the base ingredients of the care solution, the effective construction of responsive release microcapsules can prevent the base ingredients of the care solution from becoming ineffective, and only form an immediate release effect when used; 3) It can simultaneously clean stubborn contaminants that have hardened and accumulated on contact lenses over a long period of time, achieving deep cleaning. Attached Figure Description
[0048] Figure 1 This serves as a comparison of AFM characterization of sample A before and after cleaning in Example 1; Figure 2 This serves as a comparison of AFM characterization of sample B before and after cleaning in Example 1; Figure 3 This serves as a comparison of AFM characterization of sample C before and after cleaning in Example 1; Figure 4 This serves as a comparison of AFM characterization before and after sample cleaning in Comparative Example 1. Detailed Implementation
[0049] The present invention will be further described clearly and in detail below with reference to specific embodiments and the accompanying drawings. Those skilled in the art will be able to implement the present invention based on these descriptions. Furthermore, the embodiments of the present invention described below are generally only some, not all, of the embodiments of the present invention. Therefore, all other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort should fall within the scope of protection of the present invention.
[0050] Unless otherwise specified, all raw materials used in the embodiments of the present invention are commercially available or obtainable by those skilled in the art; unless otherwise specified, all methods used in the embodiments of the present invention are methods mastered by those skilled in the art.
[0051] Unless otherwise specified, the contact lens samples used in the experiments in these embodiments of the invention are all soft hydrophilic monthly disposable contact lenses (as standard experimental models), specification O. 2 Plus, National Medical Device Registration Certificate No. 20193160652.
[0052] Unless otherwise specified, accelerated aging tests are conducted according to YY / T 0719.6-2020 "Ophthalmic Optical Contact Lens Care Products" Part 6: Shelf Life Determination Guidelines, 40℃±2℃ / 65%±5% RH / protected from light, and the Arrhenius model is used to estimate the equivalent shelf life.
[0053] Example 1 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, clean microcapsules 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL; Among them, the clean microcapsules are SB-HA microcapsules, which are prepared by the following process: 1) Dissolve 10 g of N,N-dimethylethylenediamine in 50 mL of anhydrous ethanol-water solution (volume ratio of anhydrous ethanol:water = 4:1), then add 22 g of sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir at 78 °C for 12 h, then rotary evaporate until the solution volume reaches about 15 mL, then add 200 mL of acetone and stir for 30 min under ice-water bath conditions to precipitate, then filter and wash 3 times with acetone to obtain SB intermediate; 2) Sodium hyaluronate was dissolved in MES buffer (concentration 0.1 M, product label pH 5.5, purchased from Maokang Biotechnology) to prepare a 10 g / L sodium hyaluronate solution. 1 L of the prepared sodium hyaluronate solution was added to 1.0 g of SB intermediate and stirred for 5 min to mix thoroughly. Then, 2.0 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.8 g of N-hydroxysuccinimide were added. The mixture was stirred at 300 rpm for 24 h at 25 ℃. Cyclic purification was then performed. The individual cycle of the cyclic purification was as follows: the sample was filtered through an ultrafiltration tube with a molecular weight cutoff of 10 kDa → centrifuged and concentrated to 20 vol% of the original volume, followed by the addition of deionized water to replenish the original volume. A total of three cyclic purification cycles were performed. In the final cycle, after centrifugation and concentration, no deionized water was added; the sample was directly transferred to a lyophilizer for freeze-drying to obtain a white solid (SB-HA intermediate). 3) 2 g of white solid was dispersed in 200 mL of deionized water and stirred for 120 min. Then, 80 mL of 0.05 mol / L calcium chloride aqueous solution and 40 mL of 0.05 mol / L sodium citrate aqueous solution were added. The suspension was assembled by pulsed ultrasound at 200 W power. The pulsed ultrasound single cycle adopted a work-interval ratio of 3 s working and 3 s stopping, and the ultrasound assembly was performed for a total of 5 min. A mixed solution containing 40 g / L sodium thiosulfate and 40 g / L sodium citrate was prepared. 100 mL of the mixed solution was added to the suspension at a rate of 10 mL / min (i.e., 10 vol% / min) and the ultrasound treatment was continued at 100 W for 10 min. After the ultrasound treatment, the mixture was allowed to stand at room temperature of 22℃ for 120 min. Then, it was centrifuged at 6000 rpm for 10 min to obtain the solid product. The solid product was washed twice with deionized water and then freeze-dried to obtain SB-HA microcapsules.
[0054] Three main categories of tests were conducted on the contact lens solution in this case.
[0055] One major category of testing is standard performance testing, which includes product pH value, osmotic pressure, viscosity, and antimicrobial activity.
[0056] The test results and standards are shown in the table below.
[0057]
[0058] The soaking time for antimicrobial activity is 6 hours, and the number of Candida albicans and Fusarium oxysporum should not increase within 4 times the soaking time after the soaking is completed and the bacteria are killed.
[0059] The above standard performance test results show that the contact lens solution prepared in this example meets the basic national standard requirements for routine performance of contact lens solutions.
[0060] Based on this, the sample in this case also underwent a second type of test to characterize the cleaning effects of PHMB, HPMC and EDTA-2Na, with a conventional care solution (i.e. the conventional formula for removing the cleaning microcapsules in this case) serving as a control group.
[0061] Taking PHMB as an example, the sample preparation and characterization process are as follows: Adopting the new O 2 Using Plus monthly disposable contact lenses as samples, an exposure solution was prepared. Artificial tears were used as the solvent in the exposure solution (containing deionized water, sodium chloride concentration 128 mmol / L, potassium chloride 16 mmol / L, sodium bicarbonate 26 mmol / L, calcium chloride 1.0 mmol / L, magnesium chloride 0.6 mmol / L, glucose 0.1 g / L, albumin 0.5 g / L, lactoferrin 1.8 g / L, and pH adjusted to 7.4 with hydrogen chloride and / or sodium hydroxide). Artificial meibomian gland lipids were added to the artificial tears, resulting in the following final concentrations: cholesterol 0.1 g / L, cholesterol oleate 0.4 g / L, oleic acid 0.1 g / L, cetyl palmitate 0.2 g / L, L-α-phosphatidylcholine 0.05 g / L, trioleate 0.02 g / L. Finally, PHMB (final concentration 3.0 ppm) was added to prepare the exposure solution. Fresh samples were exposed to an exposure solution at 37 °C for 8 h. After exposure, the front and back of the lens were rinsed with fresh PBS solution for 5 s each. The lens was then transferred to fresh PBS solution at 37 °C for 16 h for release. After release, the lens was removed and subjected to ultrasonic extraction at 37 °C for 12 h in anhydrous methanol. The extract was then concentrated to 8% of its original volume by nitrogen blowing. The PHMB in the extract was enriched and purified by conventional SPE and characterized by HPLC-ELSD.
[0062] Samples were prepared after 1 exposure-release, 5 exposure-release, 10 exposure-release, and 30 exposure-release.
[0063] After the above samples were prepared, they were placed in the experimental group (the contact lens care solution prepared in this example) and the control group (conventional non-cleaning microcapsule care solution) for immersion and cleaning at 37 ℃ for 8 h, or rubbing and cleaning for 3 min.
[0064] The characterization and detection results are shown in the table below.
[0065]
[0066] The above characterization results clearly show that the contact lens solution prepared in this example has an excellent deep cleaning effect. After simple rinsing with the control group solution, the amount of PHMB residue on each lens hardly decreased; on the contrary, the residue generally increased, which is consistent with expectations. The exposure solution largely simulated the environment in which PHMB deposits and remains. In contrast, the control group solution, after being supplemented with PHMB, could not effectively clean deeply during the rinsing process, resulting in a "dirtier after rinsing" phenomenon. The control group sample, however, showed a significant decrease in PHMB residue after rubbing, indicating that rubbing has a certain effect on the removal of PHMB. In contrast, the experimental group samples showed a very significant PHMB removal effect after immersion. The residual PHMB in the single-exposure-release sample dropped to below 5 ng / lens after immersion in the experimental group, achieving extremely effective deep cleaning. Even the sample that had undergone 30 exposure-release cycles, with an initial residual amount as high as 24.7–25.3 ng / lens, almost reaching saturation, could be deeply cleaned with a single immersion, directly reducing the residual PHMB amount to 0.8–1.3 ng / lens. The residual amount was even much lower than that of the original sample after a single exposure-release, demonstrating an extremely excellent deep cleaning effect.
[0067] In the rubbing and washing test, the cleaning effect of the experimental group was significantly weaker than that of the immersion group. This is mainly because the two core response mechanisms of the cleaning microcapsules in the contact lens solution are based on the residual components on the lens surface. Furthermore, after contact response, the release is not an instantaneous, explosive increase. Therefore, during immersion, the effective components for deep cleaning (such as sodium thiosulfate and sodium citrate) have a sufficiently long time to be released and act. While the rubbing process triggers a third response mechanism, increasing release efficiency, the overall release and cleaning time is insufficient, resulting in a significantly weaker overall cleaning effect compared to the immersion group. Under normal circumstances, the rubbing process cannot be maintained for a long time; therefore, for the contact lens solution of this invention, overnight immersion is still the more recommended method of use. However, even the rubbing group showed a significantly better cleaning effect than the control group.
[0068] The third type of characterization mainly uses real recycled monthly, quarterly, and semi-annual disposable contact lenses as experimental samples. Due to the limited sample size and in order to conduct effective cross-comparison, each group of samples comes from the same source (from the same pair of contact lenses from the same donor), distinguishing only between the left and right eyes.
[0069] The main characterization targets were the sample roughness Ra and the chemically hardened layer formed on the contact lens surface (the main formation mechanism being a dense protein layer formed during wear due to PHMB acting as a cross-linking agent). Roughness Ra was characterized directly using AFM, while the chemically hardened layer was analyzed indirectly using XPS or a combination of AFM and other methods. + Sputtering depth profiling, since the hardened layer contains PHMB and protein, allows for the detection of the elemental composition and chemical state of the surface and shallow layers. The amount of protein deposition can be determined by the N / C (nitrogen / carbon) ratio, and the residual PHMB can be tracked by detecting Cl or S signals, thus enabling indirect analysis and calculation of the hardened layer.
[0070] Sample A information is as follows: The test sample was obtained from our company's sales department personnel, and the contact lenses used were monthly disposable contact lenses (not the aforementioned standard experimental model), used for 26 days. A fresh lens sample of the same model was used as a blank control. The comparison of the effects of cleaning the left and right lenses (Left lens / Right lens) before and after is as follows: Figure 1 As shown, the experimental group used the contact lens solution containing cleaning microcapsules prepared in this example, while the control group used the aforementioned basic formula contact lens solution without cleaning microcapsules. The cleaning method for both groups was the aforementioned constant temperature immersion and cleaning at 37 ℃ for 8 hours.
[0071] Unless otherwise specified, the left lens of the eyeglasses was cleaned with the experimental group's cleaning solution, and the right lens was cleaned with the control group's cleaning solution in subsequent tests.
[0072] from Figure 1 It is evident that the surface roughness of the left and right lens samples before cleaning was significantly increased compared to the same fresh samples. After cleaning, the right lens was cleaned using the control group, and its roughness showed almost no change compared to before cleaning. However, the roughness of the left lens decreased significantly after cleaning.
[0073] The specific characterization results are shown in the table below.
[0074]
[0075] from Figure 1Comparing the data in the table above, it is clear that the experimental group's contact lens solution can very effectively reduce and restore the surface roughness Ra of the lens, while also removing the chemically hardened layer. In contrast, the control group's contact lens solution has almost no effect on restoring the surface roughness Ra of the lens, and has no cleaning effect on the chemically hardened layer at all.
[0076] Sample B information is as follows: The test sample came from our company's sales department personnel, and the contact lenses used were quarterly disposable contact lenses (not the aforementioned standard experimental model), used for 82 days. A fresh lens sample of the same model was used as a blank control. The comparison of the effects of cleaning the left and right lenses (Left / Right lens) before and after is as follows: Figure 2 As shown, the experimental group used the contact lens solution containing cleaning microcapsules prepared in this example, while the control group used the aforementioned basic formula contact lens solution without cleaning microcapsules. The cleaning method for both groups was the aforementioned constant temperature immersion and cleaning at 37 ℃ for 8 hours.
[0077] The specific characterization results are shown in the table below.
[0078]
[0079] Sample C information is as follows: The test sample was obtained from our company's testing department personnel. The contact lenses used were six-month disposable contact lenses (not the aforementioned standard test model), and the usage period was 142 days. A fresh lens sample of the same model was used as a blank control. The comparison of the effects of cleaning the left and right lenses (Left lens / Right lens) before and after is as follows: Figure 3 As shown, the experimental group used the contact lens solution containing cleaning microcapsules prepared in this example, while the control group used the aforementioned basic formula contact lens solution without cleaning microcapsules. The cleaning method for both groups was the aforementioned constant temperature immersion and cleaning at 37 ℃ for 8 hours.
[0080] In this example, due to the increased thickness of the hardened layer, the characterization intervals were set at 10 nm to improve the efficiency of the characterization process.
[0081] The specific characterization results are shown in the table below.
[0082]
[0083] The characterization results of samples A to C clearly show that the care solution of the present invention can achieve deep cleaning very effectively. It can effectively remove the hardened layer formed on the lens surface due to long-term use, thereby effectively repairing the roughness of the lens surface. This is of great significance for deep lens care and the safety of wearers.
[0084] Example 2 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, clean microcapsules 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL; Among them, the clean microcapsules are SB-HA microcapsules, which are prepared by the following process: 1) Dissolve 10 g of N,N-dimethylethylenediamine in 50 mL of anhydrous ethanol-water solution (volume ratio of anhydrous ethanol:water = 4:1), then add 22 g of sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir at 78 °C for 12 h, then rotary evaporate until the solution volume reaches about 15 mL, then add 200 mL of acetone and stir for 30 min under ice-water bath conditions to precipitate, then filter and wash 3 times with acetone to obtain SB intermediate; 2) Sodium hyaluronate was dissolved in MES buffer (concentration 0.1 M, product label pH 5.5, purchased from Maokang Biotechnology) to prepare a 10 g / L sodium hyaluronate solution. 1 L of the prepared sodium hyaluronate solution was added to 0.8 g of SB intermediate and stirred for 5 min to mix thoroughly. Then, 2.5 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 2.0 g of N-hydroxysuccinimide were added. The mixture was stirred at 300 rpm for 24 h at 25 ℃. Cyclic purification was then performed. Each cycle of purification consisted of: filtering the sample through an ultrafiltration tube with a molecular weight cutoff of 10 kDa → centrifuging to concentrate to 20 vol% of the original volume, followed by adding deionized water to replenish the original volume. A total of three cycles of purification were performed. In the final cycle, after centrifugation and concentration, no deionized water was added; the sample was directly transferred to a freeze dryer for freeze-drying to obtain a white solid (SB-HA intermediate). 3) Disperse 2 g of white solid in 200 mL of deionized water and stir for 120 min. Then add 80 mL of 0.05 mol / L calcium chloride aqueous solution and 40 mL of 0.05 mol / L sodium citrate aqueous solution. Perform pulsed ultrasound at 200 W to assemble a suspension. The pulsed ultrasound cycle uses a work-interval ratio of 3 s on and 3 s off, and performs ultrasound assembly for a total of 5 min. Prepare a mixed solution containing 40 g / L sodium thiosulfate and 40 g / L sodium citrate. Add 100 mL of the mixed solution to the suspension at a rate of 10 mL / min (i.e., 10 vol% / min) and continue ultrasound treatment at 100 W for 10 min. After ultrasound treatment, let it stand at room temperature (22℃) for 120 min to mature. Because this sample contained small but visible gel particles, it was first ultrasound treated with a 200 W probe for 5 min to break up the gel before subsequent centrifugation. Centrifugation was performed by placing the ultrasound-broken sample in a centrifuge at 6000 rpm. The solid product was obtained by centrifugation at rpm for 10 min. The solid product was washed twice with deionized water and then freeze-dried to obtain SB-HA microcapsules.
[0085] Two main categories of tests were conducted on the contact lens solution in this case.
[0086] One major category of testing is standard performance testing, which includes product pH value, osmotic pressure, viscosity, and antimicrobial activity.
[0087] The test results and standards are shown in the table below.
[0088]
[0089] The soaking time for antimicrobial activity is 6 hours, and the number of Candida albicans and Fusarium oxysporum should not increase within 4 times the soaking time after the soaking is completed and the bacteria are killed.
[0090] The above standard performance test results show that the contact lens solution prepared in this example meets the basic national standard requirements for routine performance of contact lens solutions.
[0091] Based on this, the sample in this case also underwent a second type of test to characterize the cleaning effects of PHMB, HPMC and EDTA-2Na, with a conventional care solution (i.e. the conventional formula for removing the cleaning microcapsules in this case) serving as a control group.
[0092] Taking PHMB as an example, the sample preparation and characterization process are as follows: Adopting the new O 2Using Plus monthly disposable contact lenses as samples, an exposure solution was prepared. Artificial tears were used as the solvent in the exposure solution (containing deionized water, sodium chloride concentration 128 mmol / L, potassium chloride 16 mmol / L, sodium bicarbonate 26 mmol / L, calcium chloride 1.0 mmol / L, magnesium chloride 0.6 mmol / L, glucose 0.1 g / L, albumin 0.5 g / L, lactoferrin 1.8 g / L, and pH adjusted to 7.4 with hydrogen chloride and / or sodium hydroxide). Artificial meibomian gland lipids were added to the artificial tears, resulting in the following final concentrations: cholesterol 0.1 g / L, cholesterol oleate 0.4 g / L, oleic acid 0.1 g / L, cetyl palmitate 0.2 g / L, L-α-phosphatidylcholine 0.05 g / L, trioleate 0.02 g / L. Finally, PHMB (final concentration 3.0 ppm) was added to prepare the exposure solution. Fresh samples were exposed to an exposure solution at 37 °C for 8 h. After exposure, the front and back of the lens were rinsed with fresh PBS solution for 5 s each. The lens was then transferred to fresh PBS solution at 37 °C for 16 h for release. After release, the lens was removed and subjected to ultrasonic extraction at 37 °C for 12 h in anhydrous methanol. The extract was then concentrated to 8% of its original volume by nitrogen blowing. The PHMB in the extract was enriched and purified by conventional SPE and characterized by HPLC-ELSD.
[0093] Samples were prepared after 1 exposure-release, 5 exposure-release, 10 exposure-release, and 30 exposure-release.
[0094] After the above samples were prepared, they were placed in the experimental group (the contact lens care solution prepared in this example) and the control group (conventional non-cleaning microcapsule care solution) for immersion and cleaning at 37 ℃ for 8 h, or rubbing and cleaning for 3 min.
[0095] The characterization and detection results are shown in the table below.
[0096]
[0097] The characterization results above clearly show that the cleaning power of this example is slightly better than that of Example 1, but the shelf life of the product is slightly shortened in the additional accelerated aging test.
[0098] Example 3 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, clean microcapsules 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium EDTA 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL; Among them, the clean microcapsules are SB-HA microcapsules, which are prepared by the following process: 1) Dissolve 10 g of N,N-dimethylethylenediamine in 50 mL of anhydrous ethanol-water solution (volume ratio of anhydrous ethanol:water = 4:1), then add 22 g of sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir at 78 °C for 12 h, then rotary evaporate until the solution volume reaches about 15 mL, then add 200 mL of acetone and stir for 30 min under ice-water bath conditions to precipitate, then filter and wash 3 times with acetone to obtain SB intermediate; 2) Sodium hyaluronate was dissolved in MES buffer (concentration 0.1 M, product label pH 5.5, purchased from Maokang Biotechnology) to prepare a 10 g / L sodium hyaluronate solution. 1 L of the prepared sodium hyaluronate solution was added to 1.2 g of SB intermediate and stirred for 5 min to mix thoroughly. Then, 1.5 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.5 g of N-hydroxysuccinimide were added. The mixture was stirred at 300 rpm for 24 h at 25 ℃. Cyclic purification was then performed. The individual cycle of the cyclic purification was as follows: the sample was filtered through an ultrafiltration tube with a molecular weight cutoff of 10 kDa → centrifuged and concentrated to 20 vol% of the original volume, followed by the addition of deionized water to replenish the original volume. A total of three cyclic purification cycles were performed. In the final cycle, after centrifugation and concentration, no deionized water was added; the sample was directly transferred to a lyophilizer for freeze-drying to obtain a white solid (SB-HA intermediate). 3) 2 g of white solid was dispersed in 200 mL of deionized water and stirred for 120 min. Then, 80 mL of 0.05 mol / L calcium chloride aqueous solution and 40 mL of 0.05 mol / L sodium citrate aqueous solution were added. The suspension was assembled by pulsed ultrasound at 200 W power. The pulsed ultrasound single cycle adopted a work-interval ratio of 3 s working and 3 s stopping, and the ultrasound assembly was performed for a total of 5 min. A mixed solution containing 40 g / L sodium thiosulfate and 40 g / L sodium citrate was prepared. 100 mL of the mixed solution was added to the suspension at a rate of 10 mL / min (i.e., 10 vol% / min) and the ultrasound treatment was continued at 100 W for 10 min. After the ultrasound treatment, the mixture was allowed to stand at room temperature of 22℃ for 120 min. Then, it was centrifuged at 6000 rpm for 10 min to obtain the solid product. The solid product was washed twice with deionized water and then freeze-dried to obtain SB-HA microcapsules.
[0099] Two main categories of tests were conducted on the contact lens solution in this case.
[0100] One major category of testing is standard performance testing, which includes product pH value, osmotic pressure, viscosity, and antimicrobial activity.
[0101] The test results and standards are shown in the table below.
[0102]
[0103] The soaking time for antimicrobial activity is 6 hours, and the number of Candida albicans and Fusarium oxysporum should not increase within 4 times the soaking time after the soaking is completed and the bacteria are killed.
[0104] The above standard performance test results show that the contact lens solution prepared in this example meets the basic national standard requirements for routine performance of contact lens solutions.
[0105] Based on this, the sample in this case also underwent a second type of test to characterize the cleaning effects of PHMB, HPMC and EDTA-2Na, with a conventional care solution (i.e. the conventional formula for removing the cleaning microcapsules in this case) serving as a control group.
[0106] Taking PHMB as an example, the sample preparation and characterization process are as follows: Adopting the new O 2Using Plus monthly disposable contact lenses as samples, an exposure solution was prepared. Artificial tears were used as the solvent in the exposure solution (containing deionized water, sodium chloride concentration 128 mmol / L, potassium chloride 16 mmol / L, sodium bicarbonate 26 mmol / L, calcium chloride 1.0 mmol / L, magnesium chloride 0.6 mmol / L, glucose 0.1 g / L, albumin 0.5 g / L, lactoferrin 1.8 g / L, and pH adjusted to 7.4 with hydrogen chloride and / or sodium hydroxide). Artificial meibomian gland lipids were added to the artificial tears, resulting in the following final concentrations: cholesterol 0.1 g / L, cholesterol oleate 0.4 g / L, oleic acid 0.1 g / L, cetyl palmitate 0.2 g / L, L-α-phosphatidylcholine 0.05 g / L, trioleate 0.02 g / L. Finally, PHMB (final concentration 3.0 ppm) was added to prepare the exposure solution. Fresh samples were exposed to an exposure solution at 37 °C for 8 h. After exposure, the front and back of the lens were rinsed with fresh PBS solution for 5 s each. The lens was then transferred to fresh PBS solution at 37 °C for 16 h for release. After release, the lens was removed and subjected to ultrasonic extraction at 37 °C for 12 h in anhydrous methanol. The extract was then concentrated to 8% of its original volume by nitrogen blowing. The PHMB in the extract was enriched and purified by conventional SPE and characterized by HPLC-ELSD.
[0107] Samples were prepared after 1 exposure-release, 5 exposure-release, 10 exposure-release, and 30 exposure-release.
[0108] After the above samples were prepared, they were placed in the experimental group (the contact lens care solution prepared in this example) and the control group (conventional non-cleaning microcapsule care solution) for immersion and cleaning at 37 ℃ for 8 h, or rubbing and cleaning for 3 min.
[0109] The characterization and detection results are shown in the table below.
[0110]
[0111] Comparative Example 1 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, SB-HA composite particles 0.012 g / 100mL, α-hydrogen-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL; The SB-HA composite particles are prepared using the following process: 1) Dissolve 10 g of N,N-dimethylethylenediamine in 50 mL of anhydrous ethanol-water solution (volume ratio of anhydrous ethanol:water = 4:1), then add 22 g of sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir at 78 °C for 12 h, then rotary evaporate until the solution volume reaches about 15 mL, then add 200 mL of acetone and stir for 30 min under ice-water bath conditions to precipitate, then filter and wash 3 times with acetone to obtain SB intermediate; 2) Sodium hyaluronate was dissolved in MES buffer (concentration 0.1 M, product label pH 5.5, purchased from Maokang Biotechnology) to prepare a 10 g / L sodium hyaluronate solution. 1 L of the prepared sodium hyaluronate solution was added to 1.0 g of SB intermediate and stirred for 5 min to mix thoroughly. Then, 2.0 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.8 g of N-hydroxysuccinimide were added. The mixture was stirred at 300 rpm for 24 h at 25 ℃. Cyclic purification was then performed. The individual cycle of the cyclic purification was as follows: the sample was filtered through an ultrafiltration tube with a molecular weight cutoff of 10 kDa → centrifuged and concentrated to 20 vol% of the original volume, followed by the addition of deionized water to replenish the original volume. A total of three cyclic purification cycles were performed. In the final cycle, after centrifugation and concentration, no deionized water was added; the sample was directly transferred to a lyophilizer for freeze-drying to obtain a white solid (SB-HA intermediate). 3) Disperse 2 g of white solid in 200 mL of deionized water and stir for 120 min. Then add 80 mL of 0.05 mol / L calcium chloride aqueous solution and 40 mL of 0.05 mol / L sodium citrate aqueous solution. Stir at 300 rpm for 5 min to prepare a mixed solution containing 40 g / L sodium thiosulfate and 40 g / L sodium citrate. Add 100 mL of the mixed solution to the suspension at a rate of 10 mL / min (i.e., 10 vol% / min) and continue stirring at 300 rpm for 10 min. After stirring and mixing, let stand at 22℃ for 120 min to mature. Then centrifuge at 6000 rpm for 10 min to obtain the solid product. Wash the solid product twice with deionized water and freeze-dry to obtain SB-HA composite particles.
[0112] Two main categories of tests were conducted on the contact lens solution in this case.
[0113] One major category of testing involved characterizing the cleaning effects of PHMB, HPMC, and EDTA-2Na, with cross-sectional comparisons using samples of different freshness levels: fresh samples, accelerated aging equivalent to 1 month shelf life samples, accelerated aging equivalent to 3 months shelf life samples, and accelerated aging equivalent to 6 months shelf life samples, while also comparing them with the samples from Example 1.
[0114] Taking PHMB as an example, the sample preparation and characterization process are as follows: Adopting the new O 2Using Plus monthly disposable contact lenses as samples, an exposure solution was prepared. Artificial tears were used as the solvent in the exposure solution (containing deionized water, sodium chloride concentration 128 mmol / L, potassium chloride 16 mmol / L, sodium bicarbonate 26 mmol / L, calcium chloride 1.0 mmol / L, magnesium chloride 0.6 mmol / L, glucose 0.1 g / L, albumin 0.5 g / L, lactoferrin 1.8 g / L, and pH adjusted to 7.4 with hydrogen chloride and / or sodium hydroxide). Artificial meibomian gland lipids were added to the artificial tears, resulting in the following final concentrations: cholesterol 0.1 g / L, cholesterol oleate 0.4 g / L, oleic acid 0.1 g / L, cetyl palmitate 0.2 g / L, L-α-phosphatidylcholine 0.05 g / L, trioleate 0.02 g / L. Finally, PHMB (final concentration 3.0 ppm) was added to prepare the exposure solution. Fresh samples were exposed to an exposure solution at 37 °C for 8 h. After exposure, the front and back of the lens were rinsed with fresh PBS solution for 5 s each. The lens was then transferred to fresh PBS solution at 37 °C for 16 h for release. After release, the lens was removed and subjected to ultrasonic extraction at 37 °C for 12 h in anhydrous methanol. The extract was then concentrated to 8% of its original volume by nitrogen blowing. The PHMB in the extract was enriched and purified by conventional SPE and characterized by HPLC-ELSD.
[0115] Five exposure-release samples and 30 exposure-release samples were prepared.
[0116] After the above samples were prepared, they were placed in each experimental group for immersion and washing at a constant temperature of 37 ℃ for 8 h. The characterization and detection results are shown in the table below.
[0117]
[0118] The experimental results clearly show that the stability of the care solution in Example 1 is much higher than that in Comparative Example 1. This is because the immobilization methods of Example 1 and Comparative Example 1 are completely different. In step 3 of Comparative Example 1, mechanical stirring at 300 rpm for 5 min was used, followed by the direct addition of a sodium thiosulfate / sodium citrate mixed solution and continued stirring for 10 min. This low-shear-strength mechanical mixing cannot effectively detangle and orient the SB-HA molecular chains; the SB-HA molecular chains maintain a random coil conformation. 2+ / Cit 3- The bridging forms amorphous flocs but ordered lamellar precursors because the shear field energy provided by mechanical stirring is insufficient to break the entangled network formed between SB-HA molecules by hydrogen bonds and hydrophobic interactions. 2+It can only be randomly coordinated locally, and some sodium thiosulfate and sodium citrate exist in a free state or surface adsorbed state, failing to achieve interlayer penetration and fixation. During storage, the anti-corrosion system and the cleaning system undergo chronic redox reactions, resulting in dual-effect degradation.
[0119] The second type of characterization in this example is the same as the third type of characterization in Example 1. The equivalent 6-month aging sample of Example 1 and the equivalent 6-month aging sample of Comparative Example 1 were used for comparison. The aging sample of Example 1 was used on the left lens of the spectacle, and the aging sample of Comparative Example 1 was used on the right lens of the spectacle. The roughness Ra and the chemically hardened layer were characterized. The test samples were obtained from the company's financial personnel, and the contact lenses used were seasonal contact lenses (not the aforementioned standard experimental model) and were used for 88 days.
[0120] The roughness Ra characterization results are as follows: Figure 4 As shown in the figure. The specific characterization results are shown in the table below.
[0121]
[0122] The characterization results of the above samples clearly show that the care solution prepared in this example also has a certain effect on repairing the roughness Ra of the lens and removing the chemically hardened layer. However, the degree of repair and removal is significantly weaker than that of Example 1, and it shows a significant attenuation trend as the shelf storage time increases.
[0123] This is because, although the amorphous flocs formed by SB-HA in Comparative Example 1 can also produce a certain physical cleaning effect on the lens surface through the zwitterionic hydration repulsion of SB side chains, and a small amount of free or surface-adsorbed Na2S2O3 / Cit can play a partial reduction and chelation role in the fresh state, due to the lack of an ultrasonically induced ordered interlayer immobilization structure, the active ingredients continue to diffuse outward through the concentration gradient during storage, resulting in a serious lack of effective cleaning components that can be used to trigger release in the aged sample.
[0124] Meanwhile, the amorphous flocs lack the regular topological structure of the two-dimensional sheet precursor in Example 1. They lack clear in-plane compaction and open-edge features, exhibit no site selectivity for lipid insertion, have low trigger sensitivity, and cannot release regular nanoscale sheets to embed into microscopic pits on the lens surface after disintegration. Therefore, the repair of roughness Ra is limited to surface smoothing and cannot achieve the deep repair seen in Example 1. For the chemically hardened layer, the particles in Comparative Example 1 can only soften the outer layer of the hardened layer to a limited extent by relying on a small amount of reducing agent adsorbed on the surface. Furthermore, due to the chronic cross-reaction between the preservation and cleaning systems, the effective PHMB concentration in the care solution of the aged sample in Comparative Example 1 decreases with storage time, potentially introducing secondary microbial contamination during the cleaning process. In contrast, Example 1, due to the isolation and protection of its ordered immobilization structure, maintains a stable dual-effect balance of preservation and cleaning within an equivalent shelf life of 6 months.
[0125] Comparative Example 2 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: 1.5 ppm of polyhexamethylene biguanide hydrochloride, equivalent to (or slightly excess of) sodium thiosulfate and sodium citrate (0.005 g / 100 mL sodium thiosulfate and 0.005 g / 100 mL sodium citrate) in the same amount as in Example 1, 0.10 g / 100 mL of α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer, 0.15 g / 100 mL of hydroxypropyl methylcellulose, 0.10 g / 100 mL of disodium ethylenediaminetetraacetate, 0.5 g / 100 mL of sodium citrate, 0.35 g / 100 mL of sodium chloride, 0.55 g / 100 mL of boric acid, and 0.96 g / 100 mL of disodium hydrogen phosphate.
[0126] After one month of accelerated aging, the remaining PHMB content in the care solution of the sample in this example was characterized and compared with the sample after one month of accelerated aging in Example 1.
[0127] Characterization results showed that after one month of accelerated aging in this example, the remaining biguanide (PHMB) content was <0.1 ppm, almost undetectable. In contrast, the remaining biguanide content in the sample from Example 1 after one month of accelerated aging was still 1.4–1.5 ppm, showing almost no decrease. Furthermore, the sample from this example after one month of accelerated aging underwent the same test as the second type of detection in Example 1. The test results showed that after 30 exposure-release washes in the same manner, the PHMB concentration in the experimental sample changed from the initial 24.5–25.2 ng / lens to 24.3–25.4 ng / lens, indicating complete inactivation.
[0128] The results above show that when sodium thiosulfate and sodium citrate are added directly to the care solution in a free state without being isolated by microcapsule immobilization, the care solution undergoes a chronic redox reaction between the preservative system and the cleaning system during storage, which causes the biguanide main preservative to be reduced and ineffective in time, resulting in a complete loss of shelf-life stability.
[0129] Comparative Example 3 A contact lens care solution, which uses deionized water as a solvent, contains the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, empty microcapsules 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL.
[0130] The empty microcapsules were prepared using the following process: 1) Dissolve 10 g of N,N-dimethylethylenediamine in 50 mL of anhydrous ethanol-water solution (volume ratio of anhydrous ethanol:water = 4:1), then add 22 g of sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir at 78 °C for 12 h, then rotary evaporate until the solution volume reaches about 15 mL, then add 200 mL of acetone and stir for 30 min under ice-water bath conditions to precipitate, then filter and wash 3 times with acetone to obtain SB intermediate; 2) Sodium hyaluronate was dissolved in MES buffer (concentration 0.1 M, product label pH 5.5, purchased from Maokang Biotechnology) to prepare a 10 g / L sodium hyaluronate solution. 1 L of the prepared sodium hyaluronate solution was added to 1.0 g of SB intermediate and stirred for 5 min to mix thoroughly. Then, 2.0 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.8 g of N-hydroxysuccinimide were added. The mixture was stirred at 300 rpm for 24 h at 25 ℃. Cyclic purification was then performed. The individual cycle of the cyclic purification was as follows: the sample was filtered through an ultrafiltration tube with a molecular weight cutoff of 10 kDa → centrifuged and concentrated to 20 vol% of the original volume, followed by the addition of deionized water to replenish the original volume. A total of three cyclic purification cycles were performed. In the final cycle, after centrifugation and concentration, no deionized water was added; the sample was directly transferred to a lyophilizer for freeze-drying to obtain a white solid (SB-HA intermediate). 3) 2 g of white solid was dispersed in 200 mL of deionized water and stirred for 120 min. Then, 80 mL of 0.05 mol / L calcium chloride aqueous solution and 40 mL of 0.05 mol / L sodium citrate aqueous solution were added. The suspension was assembled by pulsed ultrasound at 200 W power. The pulsed ultrasound single cycle adopted a work-interval ratio of 3 s working and 3 s stopping, and the ultrasound assembly was performed for a total of 5 min. After the ultrasound treatment, the suspension was allowed to stand and mature at room temperature of 22℃ for 120 min. Then, the suspension was centrifuged at 6000 rpm for 10 min to obtain the solid product. The solid product was washed twice with deionized water and then freeze-dried to obtain empty microcapsules.
[0131] The same test as the second type of detection in Example 1 was performed on the sample of Comparative Example 3, and the experimental results are shown in the table below.
[0132]
[0133] The experimental results showed that the empty microcapsules of Comparative Example 3 had a certain scavenging effect on PHMB, but its scavenging efficiency was significantly lower than that of Example 1, and the scavenging efficiency decreased sharply with the increase of exposure-release cycles. Specifically, the PHMB residue in Comparative Example 3 in a single exposure-release sample was 1.5–1.9 ng / lens, which was slightly lower than the blank sample of 2.3–3.1 ng / lens, but significantly higher than the ≤0.5 ng / lens of Example 1. In the 30 exposure-release samples, the residue in Comparative Example 3 was still as high as 17.2–19.3 ng / lens, only about 20–30% lower than the blank sample of 24.4–24.9 ng / lens, and more than an order of magnitude lower than the 0.8–1.3 ng / lens of Example 1.
[0134] This is mainly because the empty microcapsules in Comparative Example 3 retained the ordered SB-HA structure formed by ultrasound induction. Their zwitterionic hydration repulsion layer can exert a certain physical cleaning effect on the lens surface. Therefore, the cleaning effect of the empty microcapsules is slightly better than the baseline control group without any microcapsules, proving that the SB-HA carrier structure itself has physical cleaning value. However, due to the lack of chemically active components such as sodium thiosulfate and sodium citrate, the empty microcapsules cannot destroy the CaO on the lens surface through chelation. 2+ / Mg 2+ The processes of metal ion bridging and the inability to reduce disulfide bonds in the hardened protein layer make it almost impossible to effectively clean stubborn pollutants that have accumulated over a long period of time.
[0135] Comparative Example 4 A contact lens care solution, which uses deionized water as a solvent, contains the following ingredients in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, SB-HA microcapsules (prepared according to Example 1) 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 2.9 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL, sample labeled D4A.
[0136] The difference between this example and Example 1 is that the amount of sodium chloride used is increased from 0.35 g / 100mL to 2.9 g / 100mL, thus increasing the total sodium content in the nursing solution. + The concentration reached approximately 650 mmol / L, without the addition of any lipid mimics or surfactants, to validate single Na+. + The effect of supercritical permeation on the stability of microcapsules.
[0137] Accelerated aging tests were conducted on the sample in this case, and samples were taken after 3 months and 6 months of accelerated aging to test the microcapsule size (DLS detection) and PHMB clearance rate.
[0138] The results of the D4A test show that: Accelerated aging after 3 months: Microcapsule particle size begins to increase (multi-disperse peaks appear in DLS detection), PHMB clearance rate decreases by approximately 23%; Accelerated aging for 6 months: The microcapsules showed obvious disintegration and turbidity, the PHMB clearance rate decreased by about 59%, and the preservative efficacy dropped below the critical value.
[0139] In another group of samples, the amount of sodium chloride was 1.4 g / 100 mL, and the formulation of the remaining components was the same as in Example 1 and D4A. The sample was labeled as D4B. Accelerated aging tests were also conducted, and samples were taken after 3 months and 6 months of accelerated aging to test the microcapsule size (DLS detection) and PHMB scavenging rate.
[0140] The test results for D4B sample show that: Accelerated aging for 3 months: No visible increase in microcapsule size, PHMB clearance rate decreased by <10%; Accelerated aging after 6 months: Microcapsule size began to increase slightly, and PHMB clearance rate decreased by about 13%.
[0141] The above characterization results indicate that, under static storage conditions without lipid intercalation, extremely high Na+ is required. + The concentration must be much higher than the standard formulation level of normal care solutions to gradually swell and destroy the polyelectrolyte network through pure osmotic pressure. The total Na content of the care solution of this invention... + The concentration was much lower than that of the single Na + The destruction threshold is determined to ensure the stability of the microcapsule structure during static storage.
[0142] Verification Example 1 A contact lens care solution, which uses deionized water as a solvent, contains the following ingredients in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, SB-HA microcapsules (prepared according to Example 1) 0.012 g / 100 mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100 mL, hydroxypropyl methylcellulose 0.15 g / 100 mL, disodium ethylenediaminetetraacetate 0.10 g / 100 mL, sodium citrate 0.5 g / 100 mL, sodium chloride 0.35 g / 100 mL, boric acid 0.55 g / 100 mL, disodium hydrogen phosphate 0.96 g / 100 mL, cholesterol oleate emulsion 0.05% (w / v).
[0143] The only difference between this example and Example 1 is the addition of 0.05% (w / v) cholesterol oleate emulsion to simulate a scenario where lipids on the lens surface accidentally flow back into the contact lens solution, verifying the interaction between trace amounts of lipids and normal sodium. + The effect of concentration synergy on the trigger threshold of microcapsules.
[0144] Accelerated aging tests were conducted on the sample in this case, and samples were taken after 1 month and 3 months of accelerated aging to test the microcapsule zeta potential, the concentration of free Na2S2O3 in the care solution, and the PHMB scavenging rate.
[0145] Expected results and mechanism explanation: Accelerated aging by 1 month: The microcapsule zeta potential showed enhanced negative charge, indicating that Ca... 2+ After being peeled off, the concentration of free Na2S2O3 in the nursing solution was detectable (>0.1 ppm). Accelerated aging over 3 months: PHMB removal rate decreased by approximately 47%, and the anti-corrosion system became significantly ineffective.
[0146] The above results indicate that trace amounts of lipids can remove Na + The critical trigger threshold drops sharply to <200 mmol / L. In the normal care solution of this invention, Na... + At certain concentrations, the presence of lipids causes the system to enter the supercritical region, triggering premature disintegration. This also demonstrates that the microcapsules of this invention, during static storage without lipid contamination, [exhibit Na]. + The concentration is safe; lipid intercalation with tear Na+ is only required during use. + Collaboration is essential for the system to rapidly enter the supercritical release zone and achieve contact-responsive release.
[0147] Comparative Example 5 A contact lens care solution, which uses deionized water as a solvent, contains the following ingredients in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, SB-HA microcapsules (prepared according to Example 1) 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium ethylenediaminetetraacetate 0.40 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL.
[0148] The only difference between this example and Example 1 is that the amount of EDTA-2Na used is increased from 0.10 g / 100 mL to 0.40 g / 100 mL, although Na + The concentration also increased accordingly, but did not exceed the relative safety threshold verified in Comparative Example 4. Therefore, this example is mainly used to verify the supercritical chelation etching of EDTA and Na. + The effect of charge shielding synergy on microcapsule stability.
[0149] Accelerated aging tests were conducted on the sample in this case, and samples were taken after 1 month and 3 months of accelerated aging to test the microcapsule zeta potential, particle size and PHMB scavenging rate.
[0150] Expected results and mechanism explanation: Accelerated aging by 1 month: Ca on the surface of microcapsules 2+ Etching with EDTA causes the Zeta potential to shift negatively; Accelerated aging in 3 months: Microcapsule disintegration, PHMB's cleaning efficiency decreases significantly to about 53%.
[0151] The above results demonstrate that high concentrations of EDTA-2Na directly chelate Ca. 2+ Bypass Na + The ion exchange pathway, with Na + Charge shielding leads to synergistic erosion. Additional experiments confirmed that the critical concentration at which EDTA-2Na may cause gradual failure of the contact lens solution is approximately 5–6 mmol / L, or about 0.19–0.22 g / 100 mL. When the EDTA concentration increases to the supercritical region, the diffusion flux gradually exceeds the dynamic equilibrium threshold, causing the network to begin etching. The sample with an EDTA-2Na concentration of 0.20 g / 100 mL showed an approximately 19% decrease in PHMB cleaning efficiency and slight turbidity after 3 months of accelerated aging. This particular sample significantly exceeded the critical concentration of EDTA-2Na, resulting in a drastically increased failure rate, with approximately half of the solution lost within three months.
[0152] Comparative Example 6 A contact lens care solution, which uses deionized water as a solvent, contains the following ingredients in varying amounts: Polyhexamethylene biguanide hydrochloride 1.5 ppm, clean microcapsules 0.012 g / 100mL, α-hydro-ω-hydroxy polyoxyethylene polyoxypropylene polyoxyethylene block copolymer 0.10 g / 100mL, hydroxypropyl methylcellulose 0.15 g / 100mL, disodium EDTA 0.10 g / 100mL, sodium citrate 0.5 g / 100mL, sodium chloride 0.35 g / 100mL, boric acid 0.55 g / 100mL, disodium hydrogen phosphate 0.96 g / 100mL; This example involves two experimental groups that yielded two sets of samples, where: 6ACit-Ca group: its clean microcapsules were prepared as SB-HA microcapsules. The preparation process was the same as in Example 1, except that the amount of calcium chloride aqueous solution in step 3) was adjusted from 80 mL to 40 mL. The rest was the same as in Example 1. 6BCa-Cit group: its clean microcapsules were prepared as SB-HA microcapsules. The preparation process was the same as in Example 1, except that the amount of calcium chloride aqueous solution in step 3) was adjusted from 80 mL to 160 mL. The rest was the same as in Example 1.
[0153] Both groups of fresh samples underwent the same standard performance tests as in Example 1, and the test results are shown in the table below.
[0154]
[0155] It is particularly noteworthy that in the 6BCa-Cit experimental group, significant mass loss occurred during washing with deionized water before the final freeze-drying in step 3) of the SB-HA microcapsule preparation process. This indicates that some microcapsules likely ruptured, suggesting that excessive calcium ions may actually damage the Ca2+. 2+ -Cit 3- The continuous topology of the coordination network. However, in the accelerated aging test, the PHMB scavenging rate of the 6BCa-Cit experimental group samples decreased more closely to that of the Sample 1 in Example 1, indicating that Ca... 2+ Excessive amounts of Cit-Ca primarily affected microcapsule construction, resulting in a certain amount of unstable and easily ruptured microcapsules. These unstable microcapsules could be effectively removed during cleaning processes, and the quality of the remaining microcapsules remained relatively stable after removal. The constructed SB-HA microcapsules still possessed a relatively complete structure, but the product yield decreased significantly by approximately 23–26 wt%, leading to a significant drop in industrial cost-effectiveness and industrial value. Meanwhile, the 6ACit-Ca experimental group samples showed a significant increase in particle size after one month of accelerated aging, and the samples exhibited slight macroscopic turbidity. This may be due to the presence of Cit-Ca. 3- Excess, Ca2 + Insufficient coordination network nodes are sparser and more susceptible to the effects of the base solvent environment of the care solution, resulting in a significantly shorter shelf life.
Claims
1. A contact lens care solution, characterized in that, The contact lens solution uses water as a solvent and comprises the following components in varying amounts: Polyhexamethylene biguanide hydrochloride 1.3–1.9 ppm, clean microcapsules 0.008–0.015 g / 100mL, α-hydrogen-ω-hydroxy polyoxyethylene-polyoxypropylene-polyoxyethylene block copolymer 0.08–0.12 g / 100mL, hydroxypropyl methylcellulose 0.12–0.18 g / 100mL, disodium ethylenediaminetetraacetate 0.08–0.12 g / 100mL, sodium citrate 0.4–0.6 g / 100mL; The clean microcapsules are SB-HA microcapsules; The SB-HA microcapsules are prepared by the following process: 1) Dissolve N,N-dimethylethylenediamine in an alcohol-water solution, then add sodium 3-chloro-2-hydroxypropanesulfonate, reflux and stir to react, then replace the precipitate with solvent and purify and dry to obtain SB intermediate; 2) Prepare a sodium hyaluronate solution, then add SB intermediate and mix well, then add 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide, stir the reaction and then purify and separate to obtain a white solid; 3) Dissolve the white solid in water and stir until homogeneous. Then add soluble calcium salt and organic sodium salt, titrate and sonicate to form a suspension. At the same time, prepare a mixed solution of sodium thiosulfate and organic sodium salt. Add the mixed solution to the suspension and continue sonication. After sonication, let it stand at room temperature to mature and separate to obtain SB-HA microcapsules. Step 2) The sodium hyaluronate solution is prepared by dissolving sodium hyaluronate in MES buffer to a concentration of 8-12 g / L. The concentration of the MES buffer used is 0.08-0.12 mol / L, and the pH value is 5.2-5.
8. Step 3) The organic sodium salt is sodium citrate.
2. The contact lens care solution according to claim 1, characterized in that, The contact lens solution also contains: Sodium chloride 0.28–0.42 g / 100mL, boric acid 0.44–0.66 g / 100mL, disodium hydrogen phosphate 0.80–1.20 g / 100mL.
3. The contact lens care solution according to claim 1, characterized in that, The alcohol-water solution in step 1) is prepared by mixing anhydrous ethanol and water in a volume ratio of (3.5-4.5):1, and the amount used is 8-12 mL / g N,N-dimethylethylenediamine; In step 1), the amount of sodium 3-chloro-2-hydroxypropanesulfonate used is 2.0 to 2.5 g / g N,N-dimethylethylenediamine.
4. A contact lens care solution according to claim 1 or 3, characterized in that, The reflux stirring reaction described in step 1) is carried out at 76–79 °C and maintained for 11–13 h. Step 1) The solvent displacement precipitation is achieved by removing ethanol under reduced pressure by rotary evaporation, adding acetone at a ratio of 15-25 mL / g N,N-dimethylethylenediamine, stirring in an ice-water bath for 25-35 min to form a precipitate, then filtering and washing with acetone at least 3 times before vacuum drying to obtain the SB intermediate.
5. The contact lens care solution according to claim 1, characterized in that, Step 2) The amount of the SB intermediate used is 0.8–1.2 g / L sodium hyaluronate solution; Step 2) The amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride used is 1.5-2.5 g / L sodium hyaluronate solution; Step 2) The amount of N-hydroxysuccinimide used is 1.5 to 2.0 g / L sodium hyaluronate solution.
6. A contact lens care solution according to claim 1 or 5, characterized in that, Step 2) The stirring reaction is carried out at 23-26 °C and 250-350 rpm for 22-26 h. Step 2) The purification and separation process involves at least three operation cycles. Each operation cycle includes, in sequence, filtration with an ultrafiltration tube with a molecular weight cutoff of 8-12 kDa, centrifugation to concentrate to 18-22 vol% of the original solution volume, and replenishment of deionized water to the original volume. After completion, an operation cycle of filtration-concentration-dilution is formed. In the last operation cycle, no deionized water is added and the solution is freeze-dried to obtain a white solid.
7. The contact lens care solution according to claim 1, characterized in that, Step 3) The soluble calcium salt is calcium chloride.
8. A contact lens care solution according to claim 1 or 7, characterized in that, Step 3) The white solid is dissolved in water at a ratio of 1 g to (80-120) mL and stirred for 90-150 min. Then, the soluble calcium salt and organic sodium salt are dissolved in water to prepare 0.04-0.06 mol / L soluble calcium salt solution and 0.04-0.06 mol / L organic sodium salt solution, respectively. The soluble calcium salt solution is added at a ratio of 35-45 mL / g white solid and the organic sodium salt solution is added at a ratio of 15-25 mL / g white solid. Then, ultrasonic assembly is performed.
9. The contact lens care solution according to claim 1, characterized in that, In step 3), the ultrasonic assembly process controls the ultrasonic probe power to be 180-220 W, forming a pulse work cycle with a work-interval ratio of 1:(0.8-1.2). The duration of a single pulse work cycle is 5-7 s, and the total ultrasonic assembly time is controlled to be 4-6 min.
10. The contact lens care solution according to claim 9, characterized in that, The ultrasonic assembly process controls the ultrasonic probe power to be 180-220 W, forming a pulse work cycle with a work-interval ratio of 1:(0.8-1.2), the duration of a single pulse work cycle is 5-7 s, and the total ultrasonic assembly time is controlled to be 4-6 min.
11. A contact lens care solution according to claim 1 or 7, characterized in that, Step 3) The concentration of sodium thiosulfate in the mixed solution is 35-45 g / L, the concentration of organic sodium salt is 35-45 g / L, and the amount of mixed solution used is 40-60 mL / g white solid.
12. The contact lens care solution according to claim 1, characterized in that, Step 3) The mixed solution is added to the suspension at a rate of 8-12 vol% / min. During the addition process, the suspension is subjected to ultrasonic treatment at 80-120 W. After the addition is completed, ultrasonic treatment at 80-120 W is continued for 8-12 min.
13. A contact lens care solution according to claim 1 or 12, characterized in that, Step 3) refers to the room temperature standing curing process, which involves standing at 18–22 °C for 90–150 min. Step 3) The separation is carried out by centrifugation at 5500-6500 rpm for 8-12 min. After separation, the solid product is washed with deionized water at least twice and then dried to obtain SB-HA microcapsules.
Citation Information
Patent Citations
Contact lenses solution
CN108148683A
Contact lens cleaner containing a microcapsular polishing agent
US5128058A
